Reference: Eric J Gowans; Stuart Roberts; Kathryn Jones; Irene Dinatale; Philippe A Latour; Brendan Chua; Emily M Y Eriksson; Ruth Chin; Shuo Li; Dominic M Wall; Rosemary L Sparrow; Jude Moloney; Maureen Loudovaris; Rosemary Ffrench; H Miles Prince; Derek Hart; Weng Zeng; Joseph Torresi; Lorena E Brown; David C Jackson. "A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals." Journal of hepatology (2010).

Epitope: CTL1, HCV core 132
Chemical type: Peptide from protein
Sequence: DLMGYIPLV
Position: 132-140
Source molecule (GenBank): BAB18806.1
Assay category: TCell
Result: Negative
Host:  39-61 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: CTL1, HCV core 132
Chemical type: Peptide from protein
Sequence: DLMGYIPLV
Position: 132-140
Source molecule (GenBank): BAB18806.1
Assay category: TCell
Result: Negative
Host:  39-61 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: CTL2, HCV core 35
Chemical type: Peptide from protein
Sequence: YLLPRRGPRL
Position: 35-44
Source molecule (GenBank): BAB18806.1
Assay category: TCell
Result: Positive-Low
Host:  39-61 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: CTL2, HCV core 35
Chemical type: Peptide from protein
Sequence: YLLPRRGPRL
Position: 35-44
Source molecule (GenBank): BAB18806.1
Assay category: TCell
Result: Negative
Host:  39-61 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: CTL3, HCV core 177
Chemical type: Peptide from protein
Sequence: FLLALLSCLTV
Position: 177-187
Source molecule (GenBank): BAA01582.1
Assay category: TCell
Result: Positive
Host:  39-61 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: CTL3, HCV core 177
Chemical type: Peptide from protein
Sequence: FLLALLSCLTV
Position: 177-187
Source molecule (GenBank): BAA01582.1
Assay category: TCell
Result: Negative
Host:  39-61 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: CTL4, HCV NS3 1406
Chemical type: Peptide from protein
Sequence: KLVALGINAV
Position: 1406-1415
Source molecule (GenBank): ABR25251.1
Assay category: TCell
Result: Positive
Host:  39-61 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: CTL4, HCV NS3 1406
Chemical type: Peptide from protein
Sequence: KLVALGINAV
Position: 1406-1415
Source molecule (GenBank): ABR25251.1
Assay category: TCell
Result: Positive
Host:  39-61 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: CTL5, HCV NS4B 1807
Chemical type: Peptide from protein
Sequence: LLFNILGGWV
Position: 1807-1816
Source molecule (GenBank): BAB18806.1
Assay category: TCell
Result: Negative
Host:  39-61 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: CTL5, HCV NS4B 1807
Chemical type: Peptide from protein
Sequence: LLFNILGGWV
Position: 1807-1816
Source molecule (GenBank): BAB18806.1
Assay category: TCell
Result: Positive-Low
Host:  39-61 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: CTL6, HCV NS4B 1851
Chemical type: Peptide from protein
Sequence: ILAGYGAGV
Position: 1851-1859
Source molecule (GenBank): BAB18806.1
Assay category: TCell
Result: Negative
Host:  39-61 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: CTL6, HCV NS4B 1851
Chemical type: Peptide from protein
Sequence: ILAGYGAGV
Position: 1851-1859
Source molecule (GenBank): BAB18806.1
Assay category: TCell
Result: Negative
Host:  39-61 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo